Finished Dosage Forms – Specials
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Acyclovir | Tablets | Herpes Zoster infections, Genital Herpes, Chickenpox. |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Parathyroid Hormone/Teriparatide/(rhPTH 1-34) | Vials & Cartridges | Osteoporosis |
| 2 | Insulin | Vials & Cartridges | Diabetes Mellitus |
| 3 | Insulin Glargine | Vials & Cartridges | Diabetes Mellitus |
| 4 | Isophane Insulin | Vials & Cartridges | Diabetes Mellitus |
| 5 | Biphasic Isophane Insulin | Vials & Cartridges | Diabetes Mellitus |
| 6 | Vitamin D3 | Solution in Mini bottele for oral use | Prevention and treatment of Vitamin D Deficiency |
| 7 | Cholecalciferol | Tablets | Prevention and treatment of Vitamin D Deficiency |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Foundaparinux | Prefilled syringe | Acure Pulvention Embolism (PE) and Acute coronary syndrome |
| 2 | Streptokinase | Vials | Arterial Thrombosis & embolism and Arteriovenous cannula acculusion |
| 3 | Enoxaparin | Prefilled syringe and Cartridges | Deep Vein Thrombosis or Acute myocardial infraction (STEMI) |
| 4 | Heparin | Vials | Prophylactic treatment of deep vein Thrombosis (DVIT) and pulmonary embolism, Prophylasix of mural Thrombosis following Myocardial Infarction. |
| 5 | Rivaroxaban | Tablets | DVT prophylaxis (Orthopedic surgery) Nonvalvular Atrial Fibrillation and DVT of PE Treatment |
| 6 | Apixaban | Tablets | Prophylaxis of deep Vein Thrombosis following Hip OrKnee Replacement surgery, treatment of DVT and PE, reduction in the Risk of Recurrence of DVT and PE |
| 7 | Dabigatran Etexilate | Capsules | Reduce the risk of stroke and systemic embolism in patients with non-valvular fibrillation. |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Interferon Alpha 2b | Lyophilized Powder Vials | Chronic Hepatitis B & C and Varied Malignancies |
| 2 | Pegylated Interferon Alpha 2b | Lyophilized Powder Vials | Corrections of alterations in intestinal bacterial flora Traveller's Diarrhoea, Viral Diarrhoea in children and antibiotic associated diarrthoea, accute gastroenteritis. |
| 3 | Bacillus Clausii | Mini Bottles for Oral use Soft Gel Capsules | Corrections of alterations in intestinal bacterial flora Traveller's Diarrhoea, Viral Diarrhoea in children and antibiotic associated diarrthoea, accute gastroenteritis. |
| 4 | Saccharomyces Boulardii | Lyophilized Power Sachets Soft Gel Capsules | Corrections of alterations in intestinal bacterial flora Traveller's Diarrhoea, Viral Diarrhoea in children and antibiotic associated diarrthoea, accute gastroenteritis. |
| 5 | Sacchromyces Boulardii+ Lactobacillus Rhamnosus + Zinc Yeast powder | Lyophilized Powder Sachets | Corrections of alterations in intestinal bacterial flora Traveller's Diarrhoea, Viral Diarrhoea in children and antibiotic associated diarrthoea, accute gastroenteritis. |
| 6 | Esomeprazone | Lyophilized Powder Vials | Gasstroesophageal reflux disease (GERD), NSAID-associated gastric ulcer, duodenal ulcer, H-Pylori associated gastric ulcers pathological hypersecretory conditions Gastric Erosive esophagitis. |
| 7 | Omeprazole | Lyophilized Powder Vials | Gasstroesophageal reflux disease (GERD), NSAID-associated gastric ulcer, duodenal ulcer, H-Pylori associated gastric ulcers pathological hypersecretory conditions Gastric Erosive esophagitis. |
| 8 | Pantoprazole | Lyophilized Powder Vials | Gasstroesophageal reflux disease (GERD), NSAID-associated gastric ulcer, duodenal ulcer, H-Pylori associated gastric ulcers pathological hypersecretory conditions Gastric Erosive esophagitis. |
| 9 | Sofosbuvir Tablets | Tablets | HCV genotype 1, 2, 3 or 4 infection |
| 10 | Bacillus clausii Soft Gel capsules | Gel Capsules | Diarrhoea |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Rasburicase | Lyophilized Powder Vials | Management of Tumor Lysis Syndrome |
| 2 | Plerixafor | Vials | Hematopoietic stem cell mobilizer, is indicated in combination with granulocyte-colony stimulating factor (G-CFS) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma. |
| 3 | Leuprolide Depot | Vials | Management of endometriosis, including pain relief and reduction of endometriotic lesions. |
| 4 | L-Asparaginase | Lyophilized Powder Vials | Acute Lymphoblastic leukemia |
| 5 | Peg-Asparaginase | Vials | Treatment of patients with Acute lymphoblastic leukemia |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Platelet Derived Growth, Factor-BB/Becaplermin | Gel | Diabetic foot ulcers |
| 2 | Platelet Dirived Growth, Factor-BB, Becaplemin+BTCP | Prefilled syringe + Powder | Periodontal tissue regeneration Powder |
| 3 | Papain - Urea | Ointment / spray | enzymatic debridement of infected wounds |
| 4 | Lonic Silver | Gel | Infected Wounds |
| 5 | Silver Wound Dressing | Sheets | Management of light to moderate drainage, partial and full thickness burns and wound |
| 6 | Sodium Chloride | Gel | Dry necrotic wounds & moist wound healing |
| 7 | Calcium Alginate | Sheets | Exudative wounds |
| 8 | Medical Grade honey | Cream | Burns, Minor cuts and abrasions |
| 9 | Cepae Ext + Heparin + Allantion | Gel | Scar reduction |
| 10 | Sub Intestinal Submucosa | Sterile Lyophilized Sheet | Growth factor enhanced wound healing matrix |
| 11 | Alcoholic lodine solution | Applicator park | Film forming preoperative skin preparation, helps reduce bacteria that cause post operative Surgical Site Infections (SSI) |
| 12 | Human Placenta Extract gel | Gel | Wounds |
| 13 | Hydrocortisone Cream | Cream | Allergic reactions, ecxeme or psoriasis. |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Immunoglobulin (IVIG) | Vials | Primary immunodeficiency Kawasaki syndrome, Idiopathic thrombocytopenic purpura, chronic B-dell lymphocytic leukemia Paediatric HIV-1 infection and haemopoietic stem cell transplatation elderly. |
| 2 | Human Serum Albumin | Vials | Hypovolaemic shoc, Burns Hypoproteinaemia, Ascites and Plasma Exchange / Dialysis |
| 3 | Factor VIII | Vials | Haemophilia A |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Snake Venom Antiserum | Lyophilized Powder Vials Vials | Treatment of envenomation caused by bites of the Snakes, as an antidote for snake bites. |
| 2 | Rabies Antiserum for Injection / Infusion | Lyophilized Powder Vials Vials | Immunization against Rabies virus |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Caspofungin | Lyophilized Powder Vials | Invasive Candidiasis and candidaemia, Oesophageal and Oropharyngeal Candidiasis, Prophylaxis of candida infection. |
| 2 | Anidulafungin | Lyophilized Powder Vials | Invasive Candidiasis and candidaemia, Oesophageal and Oropharyngeal Candidiasis, Prophylaxis of candida infection. |
| 3 | Micafungin | Lyophilized Powder Vials | Invasive Candidiasis and candidaemia, Oesophageal and Oropharyngeal Candidiasis, Prophylaxis of candida infection. |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Absorbable Gelatin Sponge | Sterile Sponge | Hemostatic sponges for surgical use |
| 2 | Thrombin (Bovine) | Lyophilized Powder Vials | Hemostar for complicated surgeries |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Hyaluronic Acid | Pre-filled Syringe | Avisco-elastic aid for cataract surgery in anterior segment |
| 2 | Hypermellose Ophthalmic solution | Pre-filled Syringe & Vials | Surgical procedures including cataract extraction and IOL implantation during keratoplasty and filtering operations for glaucoma |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Hyaluronic Acid; Hyaluronic Acid-Crosslinked | Pre-filled Syringe | A visco supplement for osteoarthritis of the Knee |
| 2 | Diclofenac sodium nano Gel | Gel | Inflammatory conditions like back pain, Arthritis,strains & sprains |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Hyaluronic acid and Lidocaine Injection | Pre-filled Syringe | A dermal filler for use in aestheric surgery |
| 2 | Hyaluronic- Acid Crosslinked | Pre-filled Syringe | A dermal filler for use in aestheric surgery |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Caffeine Citrate | Vials | Short-term treatment of apnea in premature infants |
| 2 | Rizatriptan Benzoate | Tablets | Acute treatment of migraine |
| 3 | Orlistat | Vials | Obesity Management |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Ulinastain | Vials | Severe Sepsis |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Capreomycin | Lyophilized Powder Vials | Used concomitantly with other appropriate antitubercular agents, is indicated in pulmonary infections caused by capreomycin-susceptible strains of M. Tuberculosis |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Iron (III) Isomaltoside 1000 Solution | Vials | Treatment of iron deficiency |
| 2 | Deferasirox Tablets for Suspension | Tablets | Treatment of chronic Iron overload due to blood transfusions |
| S.No | PRODUCT/ACTIVE INGREDIENT | DOSAGE FORM | APPROVED INDICATION |
| 1 | Calf Lung surfactant intratracheal Suspension | Vials | Prevention of Respiratory Distress Syndrome |
| 2 | Poractant Alfa intratracheal Suspension | Vials | Prevention of Respiratory Distress Syndrome |